The Peierls Foundation is a HSF's institutional contributors.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
May 15, 2019
ArcherDX
|
Series B | $60M | Biopharma | — |
Mar 20, 2018
ArcherDX
|
Series A | $35M | Biopharma | — |
Oct 18, 2010
BiOptix Diagnostics
|
Series B | $9M | Life Science | — |
Jun 3, 2009
Viridian Therapeutics
|
Series A | $4M | Biotechnology | — |
Sep 17, 2008
Quantia
|
Series Unknown | $5.05M | Communities | — |
The Peierls Foundation has had 3 exits. The Peierls Foundation most notable exits include ArcherDX , Viridian Therapeutics
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Dec 20, 2022 | ArcherDX | M&A | Biopharma | Detail |
Apr 24, 2017 | Viridian Therapeutics | IPO | Biotechnology | Detail |
Jan 1, 2009 | ARCA biopharma | IPO | Biotechnology | Detail |